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 Towards Understanding the Design of Dual-
modal MR/fluorescent Probes to Sense Zinc 
Ions 
C. Rivas,a G. J. Stasiuk,a M. Sae-Heng,a and N. J. Longa   
A series of gadolinium complexes were synthesised in order to test the design of dual-
modal probes that display a change in fluorescence or relaxivity response upon binding 
of zinc. A dansyl-DO3ATA gadolinium complex [GdL1] displayed an increase and a 
slight blue-shift in fluorescence in the presence of zinc, however, a decrease in 
relaxation rate was observed. Consequently, the ability of the well-known zinc chelator, 
BPEN, was assessed for relaxivity response when conjugated to the gadolinium chelate. 
The success of this probe [GdL2], lead to the inclusion of the same zinc-probing moiety 
alongside a longer wavelength emitting fluorophore, rhodamine [GdL3], to arrive at the 
final iteration of these first generation dual-modal zinc-sensing probes. The compounds 
give insight into the design protocols required for the successful imaging of zinc ions.  
 
 
Introduction 
 Being the second most abundant transition metal ion in the body, Zn2+ plays a vital role in a vast variety of biological processes.1 
Properties such as its Lewis acidic nature being critical to its enzymatic activity2, and its lack of Ligand Field Stabilization Energy 
(LFSE) conferring flexibility in its coordination geometry allowing for a variety of structural motifs3, joined together with its kinetic 
lability of coordinated ligands means that Zn2+ plays a broad utility within proteins. The majority of biological Zn2+ is bound within 
these protein structures and zinc pools exist in certain tissues to maintain homeostasis. The disruption of this homeostasis has been 
linked with a number of diseases but is poorly understood and as such, it is becoming increasingly important to develop probes that 
can detect Zn2+ in biological systems. 
 Due to its d10 electron configuration, Zn2+ is a difficult ion to detect, as it is spectroscopically silent. Therefore sensor molecules 
must be designed so that Zn2+ binding induces a characteristic change in the molecule, which can then be signalled via an imaging 
modality. Magnetic resonance (MR) and optical imaging are two modalities that lend themselves well to this sensing field, and their 
combination offers synergistic advantages. Optical imaging probes boast high sensitivity,4 an attribute that is lacking in MRI, whilst 
MRI has high special resolution and good soft-tissue contrast.5 As such the combination of the two leads to the potentially powerful 
approach for the quantitative integration of molecular and cellular information within an intact and complex body, as opposed to 
isolated in vitro systems.6 The field of optical imaging alone has produced a vast number of zinc fluorescent chemosensors, many 
of which have been reviewed extensively7 and a number of dual-modal MR/optical imaging agents based on Gd3+ have been reported 
in the literature.8 However, few ‘smart’ dual-modal probes have been designed that respond to metal ions in a biological setting. Luo 
et al. conjugated the fluorescent Zn2+ sensor 8-sulfonamidoquinoline to a Gd-DO3A moiety to produce a probe that displayed a 55% 
enhancement in r1 (3.8 to 5.9 mM-1s-1) and a 7-fold increase in fluorescence in the presence of 0.5 equivalents on Zn2+.9 These 
findings are the result of the formation of a 1:2 binding stoichiometry between GdL and Zn2+ at 0.5 eq. At a 1:1 stoichiometry the 
dianionic 8-sulfonamidoquinoline unit acts as a terdentate ligand resulting in a red-shift to 520 nm due to increased conjugation 
and a slight lowering of the relaxivity value to 5.2 mM-1s-1 was observed. The overall increase in relaxivity was attributed to the 
increased molecular weight for the Zn2+ complexes and improved molecular rigidity. 
 In order to arrive at responsive dual-modal MR/optical probes that exhibit changes in both fluorescence and relaxivity a number 
of properties should be considered. A change in the number of inner-sphere water molecules (q), the rotational tumbling time (R) 
and the residence lifetime of inner-sphere water molecules (m) will induce a change in relaxivity according to the Solomon-
Bloembergen-Morgan equation.10 The probe must also display good selectivity for Zn2+ over other biologically relevant cations such 
as Ca2+, Mg2+ and K+ and be stable and soluble in biological media. Picolylamine and di-picolylamine (dpa) units have been used as 
the most popular binding moieties to construct Zn2+ sensors.11 The dpa unit has been used extensively as part of a fluorescent 
construct but its use as part of an MR active probe has been less studied. Nagano et al. first prepared a Gd3+ complex using the 
diethylenetriaminepentaacetic acid (DTPA) ligand bifunctionalised with N,N-bis-(2-pyridyl-methyl) ethylene diamine (BPEN), a 
derivative of dpa.12 In the presence of 1 equivalent of Zn2+ the relaxivity of the complex decreased from an initial value of 6.1 to 4.0 
mM-1s-1. The initial value was obtained upon addition of a further equivalent of Zn2+. Due to the increased thermodynamic stability 
and kinetic inertness of DOTA-like macrocyclic ligands compared to DTPA, Esqueda et al. prepared a GdDOTA-bisBPEN diamide 
complex.13 In the presence of 1 equivalent of Zn2+ the relaxivity increased from 5 to 6 mM-1s-1. The 1:2 GdL:Zn2+ was found to bind 
strongly to human serum albumin (HSA) resulting in a 165% increase in relaxivity to 17.4 mM-1s-1. This significant increase was 
attributed to a slower R for the complex when bound to the protein. 
 In an attempt towards Gd3+-based responsive agents with potential application as dual-modal MR/optical probes, herein we report 
three classes of heteroditopic ligands [GdL1-3], (Figure 1), which vary in fluorophore and Zn2+ binding unit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Complexes [GdL1-3] reported. 
Results and Discussion 
[GdL1] 
Napthalene based fluorophores such as dansyl chloride have been used extensively in fluorescence imaging, and their core-structure 
can be found in the structure of many fluorescent probes used for the detection of metal ions as well as labels for amino acids, 
peptides and proteins.14 It displays spectral properties such as strong fluorescence emission and large Stokes shift, as well as being 
sensitive to pertubations in local environment, and examples can be found of its conjugation to DOTA-monoamide derivatives to 
give pH sensors or to investigate energy transfer mechanisms between it and lanthanide ions.15 As such it was selected as the 
fluorescent moiety in the first iteration of our dual-modal MR/optical zinc sensing probes.16 
 
The dansyl-DO3A-trisamide (DO3ATA) conjugate L1 was synthesised via two routes, both of which involved a four-step synthesis. 
The first route involved the reaction of amino pyridine with chloroacetyl chloride to form the amide methyl chloride 1. Reaction of 
1 with cyclen in basic conditions yielded the DO3ATA derivative 3. Conjugation of dansyl chloride to the remaining secondary 
nitrogen on cyclen gave L1 (scheme 2). The preferred route, however was to first conjugate the dansyl chloride to the cyclen core 
giving 2, and then tri-substitution with the amide methyl chloride derivative 1 gave L1 (dashed box, scheme 2). This second route 
was preferred simply due to the dansyl moiety allowing for a fluorescence handle during purification using column chromatography. 
The dansyl-DO3ATA conjugate L1 was then complexed with gadolinium to give [GdL1] in 84% yield.  
 
The fluorescence properties of [GdL1] were studies and it was found that excitation at 260 nm induced fluorescence emission at 500 
nm, as expected for a dansyl derivative. Upon addition of zinc a slight fluorescence response was observed (Figure 2a). Upon zinc 
chelation there is a small shift in emission wavelength of 10 nm from 500 to 490 nm and a 5% increase in intensity. This fluorescence 
response was found to be unique for zinc; when binding studies with other biologically relevant cations such as  
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Scheme 1:  Synthesis of dansyl-DO3AMA complex [GdL1]. 
calcium and copper were carried out, no change in fluorescence was observed (Supplementary S2). The dissociation constants were 
determined as 44.1 M (Zn2+), 364 M (Ca2+), 19 M (Cu2+) and 5.59 mM (Mg2+), suggesting that [GdL1] binds preferentially in 
the order Cu>Zn>Ca>Mg. The low affinities for Mg2+ and Ca2+ can be attributed to coordination geometry and size not being ideal 
for these group two cations. The high affinity for Cu2+ is hypothesised to be due to the octahedral geometry being more favourable 
than the tetrahedral shape of Zn2+ as the metal centres are of a similar size and charge. It must be noted that this compound is 
susceptible to transmetallation with Zn2+. This has been observed in the fluorescence spectrum, as when an excess of 10 equivalents 
of Zn2+ is added there is a significantly large increase in emission intensity which mirrors coordination to the cyclen motif observed 
by Koike et al.15 This is due to the unstable nature of the amide carbonyl bound Gd3+. 
 
Relaxation measurements of [GdL1] (400 MHz (9.4 T)) show an r1 = 3.8 mM-1s-1, which suggests a hydration state (q) of one much 
like the ‘gold standard’ MRI contrast agent Gd.DOTA (r1 = 4.2 mM-1s-1).17 This is unexpected as the coordinating ligands suggest 
that two water ligands should bind (q = 3).18 It is hypothesised that the dansyl and pyridyl arms must provide a large steric hindrance 
to block extra water ligands from binding to the Gd(III) metal centre. Also, the three amide coordinating arms are thought to slow 
water exchange rates. Lower than expected relaxation rates have also been observed by Mishra et al. with a FITC moiety conjugated 
to a DO3A motif with an r1 of 5.36 mM-1s-1.19 The relaxation rate (r1) of [GdL1] is not significantly changed when binding to zinc. 
In the presence of 1 equivalent of Zn2+ the relaxivity decreases from 3.8 to 3.2 mM-1s-1. It is postulated that the binding of Zn(II) 
ions further restricts access of the water molecules to the Gd(III) metal centre (Figure 2b).  
 
[GdL1] is a good starting point for zinc sensing dual-modal contrast agents, it has an emission at 500 nm and binds Zn with a high 
affinity over other endogenous anions, but it does fall short in that the relaxation rate decreases. It must be noted that the compound 
is not 100% soluble in water and requires 10% methanol to be dissolved, and so along with the stability issue and the non-NIR 
fluorescence it is not ideal for in vivo studies. Thus, it was decided to further design the probes to be NIR active and with a higher 
binding affinity for Zn(II). 
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Figure 2: (a) Fluorescence spectrum of [GdL1] (100 M) in MeOH in presence of increasing concentrations (0 to 5 eq.) (ex = 335 nm) of Zn2+; (b) Proposed steric hindrance 
to gadolinium centre induced by coordination of zinc to [GdL1].  
[GdL2] 
It is well known that N,N-bis-(2-pyridyl-methyl)ethylene diamine (BPEN) has a high selectivity for Zn2+ ions over other biologically 
relevant metal ions such as Ca2+ or Mg2+.20 This zinc binding moiety has been used by Nagano et al. to develop a probe that displays 
a Kd for Zn2+ of 59 nM, a value which allowed for application within biological systems.21 For this reason, [GdL2] was developed 
as a zinc binding MR probe. BPEN was prepared using a previously reported procedure following protection-derivatisation-
deprotection schemes.21 BPEN was then treated with chloroacetyl chloride to arrive at compound 4 which was then suitable for 
conjugation to DO3A under basic conditions (Scheme 3). Removal of the tert-butyl groups with trifluoroacetic acid (TFA) yielded 
L2. The ligand was coordinated to Gd3+ in a mildly acidic aqueous environment (pH ~ 5.5) (scheme 2). After purification using a 
Sephadex G-10 ion desalting resin, the absence of free lanthanide ions was verified by use of xylenol orange indicator solution.22  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2:  Synthesis of BPEN-DO3A conjugate GdL2. 
 
T1 measurements of [GdL2] were performed at 400 MHz (9.4 T, 25°C), and their r1 values over a range of Zn2+ concentrations 
determined. The relaxivity of [GdL2] increased with addition of Zn2+. In the absence of Zn2+, the relaxivity of the complex was 4.97 
mM-1s-1 (0.1 M HEPES buffer). This value increased approximately 10% with addition of Zn2+ until it levelled out at 5.39 mM-1s-1 
at equivalents of 1 and above. This small yet significant change in relaxivity is thought to be a consequence of the binding of Zn2+ 
creating a more organised second sphere of water molecules (those bound to Zn2+). 
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UV-vis. spectroscopy can also be used to study the binding of Zn2+ to the BPEN unit; the pyridine groups give a characteristic 
absorption at max = 261 nm which can be monitored over the addition of metal ions.23 The absorbance between 230 and 300 nm 
changed linearly with increasing concentrations of Zn2+ up to a 1:1 Zn2+-[GdL2] molar ratio, with isosbestic points at 252, 264 and 
269 nm and remained at a plateau with further increase of Zn2+. These significant variations in the absorption spectrum upon addition 
of Zn2+ indicate that metal-binding is indeed occurring and as such the binding constant was determined to be 55.7 M. The effect 
of adding Mg2+, Ca2+ and Cu2+ on the absorption profile was also examined. Addition of Ca2+ and Mg2+ showed a negligible effect 
on the absorption spectra of [GdL2] (246 M and unfittable respectively) whilst addition of Cu2+ provoked a significant increase 
and shift of the absorption maxima toward shorter wavelengths (ca. 256 nm). Although a greater change in absorption was observed 
with Cu2+ compared to Zn2+, a comparison of binding constants (13.8 mM vs 55.7 M) indicates clear preferential binding for Zn2+ 
over other biological metal ions showing that the BPEN fragment is suitable as a Zn2+-specific chelator. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: (Left) Water proton relaxivity of GdL2 (pH 7.4, 5 mM) in the presence of increasing concentrations (0 to 5 eq.) of Zn2+; (right) UV/vis spectra of GdL2 (100 M) 
in HEPES buffer (0.1 M; pH = 7.4) in the presence of increasing concentrations (0 to 3 eq.) of Zn2+. 
[GdL3] 
As it was found that complex [GdL2] functioned successfully as an MR active zinc-sensing probe, it was next decided to further 
modify the molecule to include a fluorescent moiety that would allow for dual-modal imaging. It was also decided to improve on 
the fluorescence properties that we observed in [GdL1] in order to have a probe which displayed improved tissue penetration through 
the use of longer emission wavelengths. Rhodamine derivatives have received significant attention as fluorescent chromophores due 
to their attractive fluorescence properties such as long absorption and emission wavelengths, large absorption coefficients and high 
quantum yields.24 The non-trival synthesis of L3 commenced with the conjugation of the rhodamine derivative 5 (synthesis described 
by Rivas et al.8) onto tBu-DO2A resulted in the tri-substituted compound 6. Subsequent substitution of the final secondary amine on 
cyclen with BPEN 4 produced the pro-ligand 7. Removal of the tert-butyl groups with trifluoroacetic acid (TFA) yielded L3. The 
ligand was coordinated to Gd3+ in a mildly acidic aqueous environment (pH ~ 5.5) resulting in formation of the dual-modal 
MR/fluorescent probe [GdL3] (scheme 3). 
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Scheme 3:  Synthesis of rhodamine-BPEN-DO2A conjugate [GdL3].  
The resulting gadolinium complex proved to be water insoluble and as such, fluorescence titrations and relaxivity experiments were 
carried out in a 50:50 MeOH:water (HEPES) solvent mixture. T1 measurements of [GdL3] were performed at 400 MHz (9.4 T, 
25°C), and their r1 values over a range of Zn2+ concentrations determined. The observed relaxation rate was 2.94 mM-1s-1 and upon 
zinc binding increased to 3.88 mM-1s-1. This lower than expected relaxation rate could be due to increased steric bulk around the 
gadolinium centre, as observed in [GdL1], and secondly with two coordinating amides, the water exchange water is significantly 
reduced. Due to the similarity of [GdL3] to [GdL2] an increase in the observed relaxivity rate was expected upon addition of Zn2+ 
and this was indeed found, with a 31% increase observed. This improved change in relaxivity rate is most probably attributed to the 
increased molecular weight of the molecule as a whole, and thus a slowing of the rotational tumbling rate, as well as an increase in 
the second sphere water ordering. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4:  (Left) Water proton relaxivity of [GdL3] (pH 7.4, 5 mM) in the presence of increasing concentrations (0 to 5 eq.) of Zn2+. (Right) Fluorescence spectra of [GdL3] 
(100 M) in 50:50 MeOH:water (HEPES buffer, 0.1 M, pH = 7.4) showing increase in fluorescence at  = 580 nm upon lowering of pH (ex = 260 nm). 
 
 
The UV-vis. absorption spectra of the complex were monitored upon addition of Zn2+ as well as the biologically relevant cations 
Cu2+, Mg2+ and Ca2+. In comparison the [GdL2], metal binding processes at the pyridyl groups can no longer be directly observed 
by UV-vis. spectroscopy as the absorption bands of the rhodamine fragment from 220 to 340 nm now dominate the spectra and 
obscure the characteristic pyridyl absorptions. To show that this probe could function as a dual-modal agent, we studied the 
fluorescence properties of the rhodamine moiety. Characteristic rhodamine emission was observed at 580 nm when an excitation 
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wavelength of 260 nm was applied (figure 5). At pH 7.4, the emission is very weak due to the spirolactam form of the rhodamine 
moiety being the most prevalent form of the compound, as observed in previous work (scheme 5). In acidic conditions however, the 
rhodamine fragment ring-opens to regenerate the strong fluorescence at  = 580 nm as seen in fig. 5 (right). Although this 
fluorescence ‘switch-on’ is not a consequence of zinc binding, we are currently working on using this result to design our next 
generation of dual-modal MRI/optical zinc sensors. By exploiting the ring-opening mechanism we hope to generate a probe that 
displays a ‘switch-on’ in fluorescence in the presence of zinc, whilst maintaining the attractive relaxivity response seen in [GdL3]. 
 
 
 
 
 
 
 
 
 
 
Scheme 5: pH-mediated ring opening of the intramolecular spirolactam of [GdL3], to give a highly fluorescent species. 
Conclusions 
 
Three first generation MR active zinc selective probes, two of which are dual-modal, based on the cyclen motif have been 
synthesised. [GdL1], the Dansyl-DO3AMA conjugate, showed slight changes in dansyl fluorescence and a decrease in relaxation 
rate from 3.8 to 3.2 mM-1s-1 upon zinc addition. These studies lead us to develop [GdL2] in order to probe the effects of the improved 
zinc-chelating moiety BPEN, and also the improved stability of the gadolinium chelate. Although this probe is not dual-modal, we 
observed an increase in relaxation rate with increased zinc concentration and this design lead to the design of dual-modal [GdL3]. 
Using the higher wavelength emitting fluorophore rhodamine, we arrived at the third iteration of the first generation probes. It 
showed an increase in relaxation rate from 2.94 to 3.88 mM-1s-1 and classical rhodamine fluorescence upon lowering of solution pH. 
Although [GdL3] has proved to be unsuitable as an imaging probe due to its lack of water solubility and lack of change in 
fluorescence intensity upon zinc addition, we now have a better understanding of what is required of a dual-modal zinc selective 
probe, and will use these results to design a series of second generation probes that show improved relaxation and NIR fluorescence 
properties.  
Experimental 
Materials and Conditions. No special precautions were taken to exclude air or moisture during reactions or workups, unless 
otherwise stated. Products tBu-DO3A25, tBu-DO2A26, BPEN21 and 58 were prepared via literature methods from commercially 
available starting materials. All other materials were purchased from commercial suppliers and used without further purificat ion. 
 
Instrumentation. 1H and 13C{1H} NMR spectra were recorded at ambient temperature on a Bruker 400 MHz spectrometer and 
internally referenced to the residual solvent peaks of CDCl3 at 7.26 ppm (1H) and 77.16 ppm {13C{1H}) or D2O at 4.79 ppm (1H). 
13C{1H} spectra were fully assigned where possible using 2D correlation spectroscopy. Mass spectrometry analyses were conducted 
by the Mass Spectrometry Service, Imperial College London. Microanalyses were carried out by Stephen Boyer of the Science 
Centre, London Metropolitan University. 
Fluorescence and UV-Vis Measurements. Absorption and fluorescence spectra of all complexes in either aqueous or methanolic 
solutions depending on solubility were obtained at room temperature on a PerkinElmer Lambda 25 spectrometer and a Cary Varian  
luminescence spectrometer (using SCAN for Windows), respectrively. Samples were held in 10 mm x 4 mm quartz Hellma cuvettes 
or BRAND UV disposable micro-cuvettes. Excitation and emission slits were set to 10:10 nm bandpass respectively.  
 
Metal Ion Titrations. 100 M solutions of the gadolinium complexes in either aqueous HEPES buffer or aqueous HEPES:methanol 
(50:50) solutions were prepared. Inorganic salts were dissolved in methanol to afford 0.025, 0.05, 0.1 and 1.25 M solutions. Aliquots 
of these solutions using the appropriate concentrations were then added to BRAND UV disposable micro-cuvettes and solvent 
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allowed to evaporate. The gadolinium complex solution was then added to the metal containing cuvettes (solution stirred for 5  
minutes) in order of increasing metal ion concentration to give solutions of 0 to 5 eq.  
 
pH Titration. A 100 M solution of GdL3 in a water:methanol (50:50) solution mixture (3 mL) was prepared. The pH of solution 
was monitored and adjusted to acidic or basic conditions using aliquots of 1M HCl or 1M NaOH, respectively. The pH was allowed 
to stabilise. Excitation wavelength of 250 nm was used.  
 
Relaxivity Measurements. Gadolinium complexes either in a water solution or a water/methanol 50:50 solution mixture were 
prepared to give 5 mM concentration solutions. The resulting solutions were placed in 1.7 mm diameter capillaries, which were 
sealed. The 1/T1 measurements were performed on a Bruker Avance 400 spectrometer (400 MHz). The concentration of Gd3+ was 
checked by the chemical shift measurement of HOD induced by magnetic susceptibility (Evans method).27 
 
Synthesis of 1. 2-(Aminomethyl)pyridine (0.95 ml, 9.25 mmol) and NEt3 (1.35 ml, 9.71 mmol) were stirred together in THF (20 ml) 
and cooled to 0 ⁰C in an ice-water bath. Chloroacetyl chloride (0.77 ml, 9.71 mmol) in THF (10 ml) was added dropwise over an 
hour. The reaction was monitored by TLC (EtOAc/MeOH = 9/1). After 4 h of stirring at room temperature, the solids were filtered, 
and the filtrates concentrated under reduced pressure. The residue was dissolved in EtOAc (40 ml) and extracted with saturated 
sodium hydrogen carbonate solution (3 x 20 ml). After drying the collective organic layers over magnesium sulphate, the solvent 
was evaporated under reduced pressure, yielding a light brown oil (1.41 g, 7.62 mmol 82 %). 1H NMR (CDCl3): δ = 8.58 (1H, d, 
3JHH = 4.76 Hz), 7.89 (1H, s br), 7.69 (1H, dt, 3JHH = 7.69 Hz, 3JHH = 1.76 Hz), 7.25 (2H, m), 4.61 (2H, d, 3JHH = 5.00 Hz), 4.13 (2H, 
s). 13C NMR (CDCl3): δ = 166.1, 155.5, 149.2, 136.9, 122.6, 122.0, 44.6, 42.6. MS (ES): m/z = 185 [M + H]+.  
 
Synthesis of 2. Dns-Cl (1.88 g, 6.97 mmol) dissolved in CHCl3 (30 ml, passed through Al2O3) was slowly added to a solution of 
cyclen (3.00 g, 17.4 mmol) and CHCl3 (60 ml). The resulting clear light green solution was left to stir at room temperature for 48 h. 
The reaction mixture was concentrated under vacuum and purified via column chromatography (DCM:MeOH, 85:15) to yield a 
bright green crystalline solid (1.90 g, 67 % yield). 1H NMR (CDCl3), δ: 8.55 (1H, 3JHH = 8.44 Hz), 8.49 (1H, d, 3JHH = 8.72 Hz, 8.22 
(1H, dd, 3JHH = 7.30 Hz, 3JHH = 0.86 Hz), 7.59 – 7.51 (2H, m), 7.19 (1H, d, 3JHH = 7.52 Hz), 3.41 (4H, t, 3JHH = 5.08 Hz), 2.89 (6H, 
s, CH3), 2.80 – 2.75 (8H, m), 2.62 (4H, t, 3JHH = 5.18 Hz). 13C NMR (CDCl3), δ: 151.8, 133.5, 130.7, 130.3, 130.2, 129.7, 128.3, 
123.2, 119.4, 115.3, 49.6, 48.6, 47.7, 45.7, 45.4. HR ESMS+ m/z calcd. for C20H31N5O2S 406.2265 [M + H]+ found 406.2270. Anal. 
Calcd for C20H31N5O2S: C, 59.23; H, 7.70; N, 17.27 %. Found C, 59.11; H, 7.66; 17.16 %. 
 
Synthesis of L1. Dns-cyclen (0.806 g, 1.99 mmol) was stirred together with acetamide (1.12 g, 6.08 mmol) and K2CO3 (0.841 g, 
6.08 mmol) in MeCN at 60⁰C. After 18 h, the solids were filtered off, and the filtrate reduced under pressure. The resulting brown 
oily residue was subjected to column chromatography on alumina (DCM - 1 % MeOH), to yield a yellow powder (0.538 g, 32 %). 
1H NMR (CDCl3), δ: 8.56 (1H, d, 3JHH = 8.44 Hz), 8.49 (2H, dd, 3JHH = 4.92 Hz, 4JHH = 0.84 Hz, 8.35 (1H, d, 3JHH = 8.72 Hz), 8.27 
(1H, t, 3JHH = 5.40 Hz), 8.17 (1H, d, 3JHH = 4.72 Hz), 8.02 (2H, t, 3JHH = 5.80 Hz), 7.99 (1H, dt, 3JHH = 7.26 Hz, 4JHH = 1.12 Hz), 7.63 
(2H, td, 3JHH = 7.67Hz, 4JHH = 1.73 Hz), 7.55 – 7.49 (2H, m), 7.48 (1H, td, 3JHH = 7.69 Hz, 4JHH = 1.73 Hz), 7.26 – 7.14 (6H, m), 
6.89 (1H, dd, 3JHH = 7.18 Hz, 3JHH = 5.14 Hz), 4.52 (4H, d, 3JHH = 5.36 Hz), 4.45 (2H, d, 3JHH = 5.12 Hz), 3.29 (4H, t, 3JHH = 6.02 
Hz), 3.19 (2H, s), 3.18 (4H, s), 3.13 (4H, t, 3JHH = 5.94 Hz), 2.91 (6H, s), 2.74 (4H, t, 3JHH = 2.72 Hz), 2.69 (4H, t, 3JHH = 2.60 Hz). 
13C NMR (CDCl3), δ: 170.8, 157.0, 156.8, 156.7, 149.4, 149.2, 149.1, 137.3, 136.1, 134.3, 130.6, 130.5, 130.4, 130.3, 128.8, 123.1, 
122.8, 122.6, 121.9, 121.8, 121.4, 121.2, 58.5, 57.5, 54.4, 53.2, 45.0, 44.6, 44.5, 44.2, 43.4. MS (ES): m/z = 850 [M]+, 851 [M + H]+, 
872 [M + Na]+. Anal. Calcd for C44H55N11O5S: C, 62.17; H, 6.52; N, 18.13 %. Found C, 62.30; H, 6.62; N 18.09 %. 
 
Synthesis of [GdL1]. Tri-acetamide-dansyl cyclen (0.248 g, 0.291 mmol) and Gd(OTf)3 (0.159 g, 0.262 mmol) were dissolved in 
MeCN (30 ml). The solution was heated under reflux for 16 h, and then concentrated. Following flash chromatography with alumina, 
the resultant yellow solution was concentrated and dissolved in a minimal amount of MeCN, followed by 100 ml of Et2O then stirring 
for a week to yield an orange powder (0.320 g, 84 %). MS (FAB+): m/z = 1007 [M]+, 1305 [M + 2CF3SO3-]2+. Anal. Calcd for 
C47H55F9GdN11O14S4: C, 38.81; H, 3.81; N, 10.59 %. Found C, 38.70; H, 3.77; N 10.63 %. 
 
Synthesis of 4. BPEN (1.45 g, 6.14 mmol) was dissolved in DCM (30 mL), NEt3 (0.94 mL, 6.75 mmol) added and the reaction 
mixture cooled to 0°C using an ice bath. Chloroacetyl chloride (0.54 mL, 6.75 mmol) was then added dropwise. The reaction mixture 
was allowed to rise to room temperature. The solution was stirred for 2 h, then the solvent was removed under reduced pressure. The 
resultant was re-dissolved in DCM (20 mL) and salts filtered. After removal of DCM the resultant was purified by alumina 
chromatography with DCM to afford 4 as a pale yellow oil (1.25 g, 64%). 1H NMR (400 MHz, CDCl3) δ (ppm) = 2.93 (t, 2H, 3JHH 
= 5.6 Hz), 3.47 (m, 2H,), 4.04 (s, 2H), 4.07 (s, 4H), 7.34 (m, 2H), 7.55 (d, 2H, 3JHH = 7.6 Hz), 7.80 (td, 2H, 3JHH = 8 Hz, 4 Hz), 8.66 
 
 
(d, 2H, 3JHH = 5.2 Hz). 13C NMR (100 MHz, CDCl3) δ (ppm) = 37.17, 42.59, 53.30, 58.55, 123.47, 124.62, 138.81, 147.54, 156.11, 
166.72. HR ESMS+ m/z calcd for C16H20N4OCl 319.1326 [M + H]+, found 319.1339. 
 
Synthesis of 5. Tris-tert-butyl-DO3A (0.9 g, 1.4 mmol) and K2CO3 (0.2 g, 1.6 mmol) were dissolved in MeCN (30 mL) and left to 
stir for 5 min. 4 (0.5 g, 1.6 mmol) in MeCN (10 mL) was then added dropwise. The reaction mixture was set to reflux for 24 h. The 
resulting solution was filtered and the filtrate concentrated under reduced pressure. The crude product was purified by Al 2O3 
chromatography using 1-10% MeOH/DCM, affording 5 as a beige solid (0.68 g, 54%). 1H NMR (400 MHz, CDCl3) δ (ppm) = 1.37 
(s, 27H), 2.17-3.41 (m, 28 H), 3.80 (s, 4H), 7.09 (m, 2H), 7.33 (d, 2H, 3JHH = 8 Hz), 7.56 (td, 2H, 3JHH = 7.6 Hz, 1.6 Hz), 8.48 (d, 
2H, 3JHH = 4.4 Hz) . 13C NMR (100 MHz, CDCl3) δC = 28.14, 37.51, 42.67, 44.00, 45.04, 47.09, 49.26, 51.10, 51.43, 52.17, 57.67, 
59.91, 81.54, 122.21, 123.62, 149.99, 158.88, 165.86, 169.81, 170.5, 171.73. HR ESMS+ m/z calcd for C42H68N8O7 797.5289 [M]+ 
, found 797.5290. Anal. Calcd for C42H68 K2N8O7: C, 57.64; H, 7.83; N, 12.80 %. Found C, 56.90; H, 7.80; N, 12.85 %. 
 
Synthesis of L2. 5 (0.15 g, 0.19 mmol) was dissolved in CH2Cl2 (5 mL), and trifluoroacetic acid (5 mL) was added dropwise. The 
solution was stirred at room temperature, open to air, for 24 h. The solvents were removed in vacuo and the residue was redissolved 
in CH2Cl2. This was repeated with diethyl ether and again with CH2Cl2 until L2 was obtained as a white powder (0.17 g, TFA salts 
present). 1H NMR (400 MHz, D2O) δ (ppm) = 2.26 (br, 2H), 2.79-3.83 (br m, 24H), 4.10 (s, 8H), 7.85 (t, 2H, 3JHH = 6.8 Hz), 7.95 
(d, 2H, 3JHH = 8 Hz), 8.40 (t, 2H, 3JHH = 7.6 Hz), 8.56 (d, 2H, 3JHH = 5.6 Hz). 13C NMR (100 MHz, D2O) δC = 36.66, 49.25, 51.34, 
53.98, 55.29, 117.70, 126.31, 127.35, 141.83, 147.83, 152.40, 162.98, 174.05, 174.60. HR ESMS+ m/z calcd for C30H45N8O7 
629.3411[M + H]+, found 629.3428. 
 
Synthesis [GdL2]. L2 (0.10 g, 0.16 mmol) and GdCl3.6H2O (0.059 g, 0.16 mmol) were dissolved in water (4 mL), and the pH was 
adjusted to 5.5 using 2 M NaOH solution. The mixture was stirred at room temperature for 24 h. The pH was increased to 10 by 
addition of 2 M NaOH to precipitate uncomplexed Gd3+, pH taken back to 7.4 and water removed. The residue was purified by 
Sephadex G10 desalting resin to yield [GdL2] as a white powder (0.0091g, 7%). HR ESMS+ m/z calcd for C30H42GdN8O7 784.2418 
[M + H]+, found 784.2446. r1 (H2O, 298 K, 400 MHz) = 4.55 mmol-1s-1; abs = 262 nm. 
 
Synthesis of 6. Bis-tert-butyl-DO2A (1.5 g, 3.8 mmol) and K2CO3 (0.52 g, 3.8 mmol) were dissolved in MeCN (130 mL) and left 
to stir for 5 min. 5 (2.11 g, 3.8 mmol) was then added. The reaction mixture was set to reflux for 24 h. The resulting solution was 
filtered and the filtrate concentrated under reduced pressure. The crude product was purified by Al2O3 chromatography using 1-2% 
MeOH/DCM, affording 6 as a pale pink solid (1.59 g, 46%). 1H NMR (400 MHz, CDCl3) δ (ppm) = 1.17 (t, 12H, 3JHH = 7.2 Hz), 
1.47 (s, 18H), 2.40-3.10 (series of multiplets, 24H), 3.22 (m, 2H), 3.32 (q, 8H 3JHH = 7.2 Hz), 6.30 (dd, 2H, 4JHH = 2.6 Hz, 3JHH = 
8.8 Hz), 6.39 (d, 2H, 4JHH = 2.6 Hz), 6.50 (d, 2H, 3JHH = 8.8 Hz), 7.06 (m, 1H), 7.43 (m, 2H), 7.92 (m, 1H), 8.08 (br s, 1H). 13C NMR 
(100 MHz, CDCl3) δC = 12.65, 28.22, 37.70, 39.86, 44.33, 48.78, 52.44, 53.42, 55.86, 56.85, 57.21, 64.90, 80.91, 97.82, 105.32, 
108.20, 122.85, 123.74, 127.95, 128.70, 130.61, 132.44, 148.80, 153.14, 153.98, 168.56, 170.89, 171.98. HR ESMS+ m/z calcd for 
C52H77N8O7 925.5915 [M]+, found 925.5920. Anal. Calcd for C52H76N8O7: C, 67.50; H, 8.28; N, 12.11 %. Found C, 67.39; H, 8.17; 
N, 12.02 %. 
 
Synthesis of 7. 6 (1.2 g, 1.3 mmol) and K2CO3 (0.2 g, 1.6 mmol) were dissolved in MeCN (40 mL) and left to stir for 5 min. 4 (0.5 
g, 1.5 mmol) in MeCN (10 mL) was then added dropwise. The reaction mixture was set to reflux for 24 h. The resulting solution 
was filtered and the filtrate concentrated under reduced pressure. The crude product was purified by Al2O3 chromatography using 1-
10% MeOH/DCM, affording 7 as a beige solid (0.68 g, 34%). 1H NMR (400 MHz, CDCl3) δ (ppm) = 1.14 (t, 12H, 3JHH = 6.8 Hz), 
1.35 (s, 18H), 2.47-3.56 (series of multiplets, 28H), 3.32 (q, 8H, 3JHH = 6.8 Hz), 3.82 (s, 4H), 6.35 (br m, 6H), 7.04 (m, 1H), 7.12 
(m, 2H), 7.40 (m, 2H), 7.64 (m, 4H), 7.80 (m, 1H), 8.46 (d, 2H, 3JHH = 4.8 Hz), 9.81 (t, 1H, 3JHH = 5.3 Hz), 10.57 (t, 1H, 3JHH = 5.5 
Hz). 13C NMR (100 MHz, CDCl3) δC = 12.63, 27.97, 38.03, 38.95, 39.85, 44.29, 48.78, 50.27, 53.25, 56.83, 57.04, 59.96, 65.17, 
86.25, 97.74, 122.04, 122.96, 123.34, 123.71, 127.88, 130.00, 132.64, 136.69, 148.80, 154.08, 159.20, 169.07, 173.52, 174.54. HR 
ESMS+ m/z calcd for C68H94 N12NaO8 1229.7215 [M + Na]+. Found 1229.7219. 
 
Synthesis of L3. 5 (0.44 g, 0.36 mmol) was dissolved in CH2Cl2 (10 mL), and trifluoroacetic acid (10 mL) was added dropwise. The 
solution was stirred at room temperature, open to air, for 24 h. The solvents were removed in vacuo and the residue was redissolved 
in CH2Cl2. This was repeated with diethyl ether and again with CH2Cl2 until L3 was obtained as a bright pink powder (0.13 g, TFA 
salts present). 1H NMR (400 MHz, D2O) δ (ppm) = 1.03 (t, 12H, 3JHH = 7.2 Hz), 2.69-3.46 (series of multiplets, 32H), 3.55 (q, 8H, 
3JHH = 7.2 Hz), 4.12 (s, 4H), 6.98 (d, 2H, 3JHH = 8.8 Hz), 7.09 (dd, 1H, 3JHH = 6 Hz, 4JHH = 2 Hz), 7.12 (dd, 2H, 3JHH = 8.4 Hz, 4JHH 
= 2 Hz), 7.51 (d, 2H, 3JHH = 2 Hz), 7.56 (m, 2H), 7.79 (t, 2H, 3JHH = 6.8 Hz), 7.87 (m, 1H), 7.94 (d, 2H, 3JHH = 8 Hz). 13C NMR (100 
MHz, D2O) δC = 9.63, 14.08, 53.82, 54.98, 65.98, 110.00, 111.93, 112.19, 114.83, 117.73, 118.26, 120.33, 126.30, 127.25, 130.80, 
138.46, 141.74, 147.25, 152.04, 152.45, 161.22, 162.57, 162.93. HR ESMS+ m/z calcd for C60H78N12O8 1095.6144 [M]+. Found 
1095.6125. 
 
Synthesis of [GdL3]. L3 (0.3 g, 0.27 mmol) and GdCl3.6H2O (0.1 g, 0.27 mmol) were dissolved in water (12 mL), and the pH was 
adjusted to 5.5 using 2 M NaOH solution. The mixture was stirred at room temperature for 24 h. The precipitate formed was filtered 
and washed with water. It was then dissolved in a 50:50 MeOH:water mix and the pH of the solution was increased to 10 by addition 
of 2 M NaOH to precipitate uncomplexed Gd(OH)3. After pH taken back to 5.5 DOWEX Mac-3 weak acid-cation exchange resin 
beads were added and solution stirred for 10 mins. After removal of bead and solvent, [GdL3] was obtained as a pale brown powder 
(0.092, 29%). HR ESMS+ m/z calcd for C60H76GdN12O8 1250.5150 [M]+. Found 1250.5151. 
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